SL Bionics "Claims of Sales Ban Order Are Groundless"

[Asia Economy Reporter Jang Hyowon] SL Bionics clarified on the 22nd that the claim that Seoul Viosys received a sales ban order from a U.S. court in a lawsuit against customers selling SL Bionics products is groundless.

Regarding Seoul Viosys's claim of a sales ban order, SL Bionics stated that although Seoul Viosys did file a lawsuit in the U.S. against companies using its products, the lawsuit was settled through an agreement between the two companies. The court merely respected and approved the parties' agreement, so the claim is not true.

An SL Bionics official emphasized, "The specific terms of the agreement involved Seoul Viosys agreeing not to sell in the U.S. only for one of the 11 patents it claimed were infringed, and both companies agreed to allow the sale of existing inventory. The court would never issue an order permitting the sale of inventory if it were an infringing product."

He added, "The parties' agreement is being distorted as if it were a court ruling of infringement, leading to the mistaken belief that our products are infringing. We believe this article could damage the company's external image and cause anxiety among customers. Therefore, we will promptly secure credible evidence to support our claims and explain that our products do not infringe any patents."

This content was produced with the assistance of AI translation services.